Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
SHSE:688212's PEG Ratio is ranked worse than 97.1% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs SHSE:688212: 22.67
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Shanghai Aohua Photoelectricity Endoscope Co PEG Ratio Related Terms
Shanghai Aohua Photoelectricity Endoscope Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Aohua Photoelectricity Endoscope Co PEG Ratio Chart
Shanghai Aohua Photoelectricity Endoscope Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Aohua Photoelectricity Endoscope Co PEG Ratio vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) has a PEG Ratio of 22.67 as of Jul. 25, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shanghai Aohua Photoelectricity Endoscope Co and its competitors. This is 184% above median its historical median of 7.99. Over the past decade, Shanghai Aohua Photoelectricity Endoscope Co's PEG Ratio has ranged from 5.02 to 46.84. According to the industry distribution chart, Shanghai Aohua Photoelectricity Endoscope Co ranks #201 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 97.1%.
Is Shanghai Aohua Photoelectricity Endoscope Co's PEG Ratio too high?
Shanghai Aohua Photoelectricity Endoscope Co's current PEG Ratio of 22.67 is 184% above median its 10-year median of 7.99. Over the past 10 years, this metric has ranged from a low of 5.02 to a high of 46.84. The Medical Devices & Instruments industry median PEG Ratio is 1.89. Shanghai Aohua Photoelectricity Endoscope Co's value of 22.67 is 1099.5% above this industry median. Based on the distribution chart, Shanghai Aohua Photoelectricity Endoscope Co ranks #201 out of 207 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghai Aohua Photoelectricity Endoscope Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Aohua Photoelectricity Endoscope Co's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Aohua Photoelectricity Endoscope Co ranks #201 out of 207 companies for PEG Ratio. This places Shanghai Aohua Photoelectricity Endoscope Co in the lower half of its industry. The industry median PEG Ratio is 1.89. Shanghai Aohua Photoelectricity Endoscope Co's value of 22.67 is 1099.5% above this benchmark. Historically, Shanghai Aohua Photoelectricity Endoscope Co's own PEG Ratio has ranged from 5.02 to 46.84 over the past decade. While the company's 10-year median is 7.99 vs. the industry median of 1.89, Shanghai Aohua Photoelectricity Endoscope Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.89, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Aohua Photoelectricity Endoscope Co's current PEG Ratio of 22.67 is 1099.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shanghai Aohua Photoelectricity Endoscope Co and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Aohua Photoelectricity Endoscope Co's current PEG Ratio is 22.67, which is 184% above median its own 10-year median of 7.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Aohua Photoelectricity Endoscope Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥61.99, compared to a current price of ¥25.37 — trading 59.1% below its estimated fair value. The current PEG Ratio is 22.67, which is 184% above median its 10-year median of 7.99 and 1099.5% above the Medical Devices & Instruments industry median of 1.89. Shanghai Aohua Photoelectricity Endoscope Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212), the current PEG Ratio is 22.67 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Aohua Photoelectricity Endoscope Co stock appears to be undervalued.
The current stock price of ¥25.37 is trading 59.1% below its estimated GF Value™ of ¥61.99.
GuruFocus considers Shanghai Aohua Photoelectricity Endoscope Co to be Significantly Undervalued.
Key valuation signals for SHSE:688212:
PEG Ratio: 22.67 (184% above median its 10-year median of 7.99)
GF Value™: ¥61.99 vs. price of ¥25.37 (59.1% below fair value)
Industry Position: 1099.5% above the Medical Devices & Instruments median (#201 of 207)
No single metric tells the full story. See the SHSE:688212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Aohua Photoelectricity Endoscope Co Business Description
Shanghai Aohua Photoelectricity Endoscope Co Ltd is engaged in the research and development, production and sales of electronic endoscope equipment and endoscope diagnostic and surgical consumables.
70GF Score
Get the complete analysis for SHSE:688212
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688212 has been successfully added to your 
